NASDAQ: HCM
Hutchmed Ltd Stock Forecast, Predictions & Price Target

Analyst price target for HCM

Based on 2 analysts offering 12 month price targets for Hutchmed Ltd

Min Forecast
$14.00-0.36%
Avg Forecast
$15.50+10.32%
Max Forecast
$17.00+21%

Should I buy or sell HCM stock?

Based on 2 analysts offering ratings for Hutchmed Ltd.

Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their HCM stock forecasts and price targets.

HCM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-07-23
lockedlocked$00.00+00.00%2026-07-07

1 of 1

HCM vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
HCM$14.05$15.50+10.32%Buy
PBH$49.92$72.00+44.23%Buy
BHC$6.30$9.00+42.86%Hold
PRGO$16.63N/AN/A
SUPN$37.88$67.00+76.87%Strong Buy

Hutchmed Stock Forecast FAQ

Is Hutchmed Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: HCM) stock is to Buy HCM stock.

Out of 2 analysts, 1 (50%) are recommending HCM as a Strong Buy, 0 (0%) are recommending HCM as a Buy, 1 (50%) are recommending HCM as a Hold, 0 (0%) are recommending HCM as a Sell, and 0 (0%) are recommending HCM as a Strong Sell.

If you're new to stock investing, here's how to buy Hutchmed stock.

What is HCM's Price Target?

According to 2 Wall Street analysts that have issued a 1 year HCM price target, the average HCM price target is $15.50, with the highest HCM stock price forecast at $17.00 and the lowest HCM stock price forecast at $14.00.

On average, Wall Street analysts predict that Hutchmed's share price could reach $15.50 by Jul 23, 2027. The average Hutchmed stock price prediction forecasts a potential upside of 10.32% from the current HCM share price of $14.05.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.